Global Trends
-
European Authorities Clear Novel Autoimmune Therapy for Myasthenia Gravis
The European Commission has granted authorization for nipocalimab, an immunoglobulin G (IgG) receptor antagonist developed by Johnson & Johnson, for…
Read More » -
Vetter Managing Director to Retire Following Over Three Decades of Service
Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has announced the retirement of its Managing Director, Thomas Otto,…
Read More » -
New Study Suggests Shingles Vaccine May Slow Cognitive Decline
A new follow-up study, published in the journal Cell, adds evidence that the shingles vaccine, a two-dose shot recommended for…
Read More » -
Bristol Myers Bolsters Scale of Cobenfy Trial After Discovery of Site Irregularities
Bristol Myers Squibb (BMS) has announced an extension and increased enrollment for its late-stage clinical trial, “ADEPT-2,” of the drug…
Read More » -
Senior FDA Drug Regulator Steps Down Shortly After Appointment
The U.S. Food and Drug Administration (FDA) is once again searching for a leader for its Center for Drug Evaluation…
Read More » -
AI Chemistry Outfit Secures $95 Million to Accelerate Small Molecule Discovery and Production
Excelsior Sciences, an artificial intelligence (AI) chemistry firm, is gaining ground on its mission to hasten the discovery and production…
Read More » -
Campaign Raises Vision Health Awareness Targeting Aging Women
The Johnson & Johnson (J&J) corporation has teamed up with the acclaimed actress Naomi Watts in a communication campaign to…
Read More » -
New Leadership to Drive Strategic Growth in the Americas Region
Evonik, a global specialty chemicals company, has named executive Elias Lacerda President of the Americas region, effective February 1, 2026.…
Read More » -
Tech and Pharma Alliance Drives Patient-Centric Drug Development
The organization Citizen Health has entered into a multi-year strategic partnership with the pharmaceutical company UCB to expedite drug development…
Read More » -
Historic Zero Tariff Pharmaceutical Deal Agreed Between US and UK
The US government and the United Kingdom have announced an agreement in principle regarding pharmaceutical trade, under which UK pharmaceutical…
Read More » -
-
US-UK Trade Deal: Drug Tariff Exemption Secured in Exchange for Healthcare Spending Reforms
Source: https://www.fiercepharma.com/pharma/trump-administration-locks-trade-deal-setting-uk-drug-tariffs-zero
Read More » -
Instability Signals and New Opportunities in the Rare Cardiovascular Market (ATTR-CM)
The burgeoning field of transthyretin amyloid cardiomyopathy (ATTR-CM)—once projected to become a $20 billion market—may have just revealed the first…
Read More » -
-
Uncontrollable Vomiting Syndrome on the Rise: Warning Linked to Chronic Cannabis Use
A rare and unusual medical condition, known as Cannabis Hyperemesis Syndrome (CHS), is escalating in the United States. The disorder…
Read More » -
Top FDA Drug Officer Set to Exit Weeks into New Role
The long-serving oncology chief of the U.S. Food and Drug Administration (FDA) has filed to retire from the agency, just…
Read More » -
Global Health Policy Shift: US No Longer Commemorating World AIDS Day
The United States government has decided not to commemorate World AIDS Day this year on December 1, an observance that…
Read More » -
Leadership Change at Vaccine Advisory Committee Amid Controversial Recommendations
A senior official from the U.S. Department of Health and Human Services (HHS) announced on Monday that the controversial Advisory…
Read More » -
FDA Official Plans Vaccine Approval Process Overhaul Following Internal Analysis
A senior official from the U.S. Food and Drug Administration (FDA) announced on Friday that the agency will change its…
Read More » -
Eli Lilly and NVIDIA Announce Partnership to Build Advanced AI Supercomputer
Pharmaceutical giant Eli Lilly and technology firm NVIDIA have disclosed a collaboration to construct a new supercomputing system. The project…
Read More »